A prospective multicenter clinical trial evaluating the efficacy and safety of a hyaluronic acid-based filler with Tri-Hyal technology in the treatment of lips and the perioral area.

J Cosmet Dermatol · 2023 · PMC10087550 · PMID 35718985

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp < 0.0001actually significant

Improvements were highly significant compared to baseline for nasolabial folds (mean D0: 2.7 (0.4) vs. mean D540: 1.7 (0.6), p < 0.0001) and marionette lines (mean D0: 2.6 (0.4) vs. mean D540: 1.7 (0.7), p < 0.0001) at 540 days post‐injection and at 450 days post‐injection for lips (mean D0: 1.0 (0.5) vs. mean D450: 1.2 (0.5), p = 0.0326).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.